2017 American Transplant Congress
Factors in Association with Sepsis Differ Between Simultaneous Pancreas/Kidney and Single Kidney Transplant Recipients.
As immunosuppressive therapy and allograft survival have improved in simultaneous pancreas/kidney transplant recipients (SPKTRs), the increased incidence of infection has become a major hurdle of…2017 American Transplant Congress
Myeloid HO-1 Regulates M2 Macrophage Activation in Liver Ischemia-Reperfusion Injury (IRI).
Background/Aim: Although anti-inflammatory macrophage differentiation (M2) from pro-inflammatory (M1) phenotype is critical for heme oxygenase-1 (HO-1) cytoprotection, the role of cell type-specific HO-1 induction remains…2017 American Transplant Congress
Prolonged Liver Ischemia Triggers Necrotic Depletion of TIM4+ Kupffer Cells to Facilitate Tissue Inflammatory Immune Activation in Liver Ischemia-Reperfusion Injury.
Although mechanisms of immune activation against liver ischemia-reperfusion injury (IRI) have been studied extensively, questions regarding liver resident Kupffer cells vs. infiltrating macrophages (iM[Oslash]s) remain…2017 American Transplant Congress
Predictive Value of Renal Transplant Scintigraphy for the Duration of Delayed Graft Function.
Background: Renal scintigraphy (RS) is a widely used test for the assessment of the transplanted kidney (KTX). As RS cannot reliably distinguish between rejection and…2017 American Transplant Congress
Treatment of Post-Transplant Nephrotic Syndrome with Adrenocorticotropic (ACTH) Gel.
1Medstar Georgetown Transplant Institute, Washington DC; 2Indiana University Health, Indianapolis
Objectives: Post-kidney transplant proteinuria due to recurrent GN is considered to be a significant risk factor negatively affecting kidney transplant survival. In this case series…2017 American Transplant Congress
Optimal Induction Therapy for Kidney Transplantation in Previous Heart Transplant Recipients: Analysis of OPTN/UNOS Registry.
Nephrology, Internal Medicine, Allegheny General Hospital, Pittsburgh, PA
It is unclear as to which induction agent is optimal for kidney transplant (KT) in prior heart transplant (HT) recipients who are already immunocompromised from…2017 American Transplant Congress
Reduced Rituximab with Prophylactic Antibiotic Treatment Improves the Infectious Complications in Patients Undergoing ABO-Incompatible Living Donor Liver Transplantation.
Organ Transplantation, China Medical University Hospital, Taichung, Taiwan
Introduction:ABO incompatible (ABOi) living donor liver transplantation (LDLT) is a feasible alternative for donor liver allograft in emergency situations. The reported outcomes of ABOi-LDLT after…2017 American Transplant Congress
Risk Analysis of Patients with Proven Coronary Artery Disease Undergoing Liver Transplant.
Houston Methodist Hospital, Houston, TX
ObjectivesCoronary artery disease is increasing common in liver transplant (LT) candidates due to the aging population. We sought to longitudinally evaluate of outcomes of LT…2017 American Transplant Congress
Patency of Autologous Portal Vein “Y“ Graft in Anterior Sector Outflow Reconstruction in Adult Living Donor Right Lobe Grafts.
Anetrior sector outflow reconstruction is followed by most centers performing right lobe liver transplantation. Recanalised umbilical vein, cryopreserved cadaveric veins/ arteries, PTFE and Recipient's portal…2017 American Transplant Congress
Felodipine Diminishes Decline in Glomerular Filtration Rate in Lung Transplanted Patients Treated with Cyclosporine: A Randomized Placebo Controlled Trial.
Background. Calcium channel blockers may ameliorate the decline in renal function caused by calcineurin inhibitors in lung transplant (LTX) recipients. We previously demonstrated a 47…
- « Previous Page
- 1
- …
- 92
- 93
- 94
- 95
- 96
- …
- 181
- Next Page »